Effective method for the detection of piroxicam in human plasma using HPLC
AUTOR(ES)
CALVO, Adriana Maria, PRADO, Mariel Tavares de Oliveira, DIONÍSIO, Thiago José, MARQUES, Maria Paula, BROZOSKI, Daniel Thomas, LANCHOTE, Vera Lúcia, FARIA, Flávio Augusto Cardoso, SANTOS, Carlos Ferreira
FONTE
Braz. oral res.
DATA DE PUBLICAÇÃO
20/05/2016
RESUMO
Abstract Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used by the general population to alleviate inflammation and pain after oral surgeries. Piroxicam is among the most commonly used NSAIDs and excels in controlling pain, swelling, trismus and other common symptoms of inflammation. This study aimed to evaluate different concentrations of piroxicam and its major metabolite, 5’-hydroxypiroxicam, in human plasma samples over time using high performance liquid chromatography (HPLC) after liquid-liquid extraction. Briefly, 10 volunteers participated in this study after approval by the Ethics Committee of Bauru School of Dentistry, Universidade de São Paulo – USP, Brazil. Volunteers received a single dose oral of piroxicam (20 mg) and had blood collected at various times following an established protocol. The methodology of liquid-liquid extraction was effective for determining concentrations of piroxicam in plasma using HPLC in 10 out of 10 volunteers while 5’-hydroxypiroxicam was only detected in 2 out of 10 volunteers.
Documentos Relacionados
- Erratum: Effective method for the detection of piroxicam in human plasma using HPLC
- HPLC method development and validation for the estimation of Axitinib in rabbit plasma
- Method development and validation for naratriptan determination in human plasma by HPLC with tandem mass spectrometry detection, and its application to bioequivalence study
- Determination of etimicin in rat plasma using 9-fluorenylmethyl chloroformate precolumn derivatization by HPLC with fluorescence detection
- Analysis of human plasma and urine purines using high performance liquid chromatography (HPLC)
